On May 22, AB 228 (Aguiar-Curry) passed the California Assembly unanimously and is now on its way to the Senate where it will first be heard next month in the Senate Health Committee. If passed, the legislation would help resolve issues in the state involving hemp-derived products, including products containing cannabidiol (CBD), and pave the way for the California Department of Public Health (CDPH) to regulate the processing and sale of these products.